A chemistry and biology graduate of the University of Northern Iowa, Dr. Rathmell earned her PhD in biophysics and MD from Stanford University. She did an Internal Medicine internship at the University of Chicago before attending the University of Pennsylvania where she completed an Internal Medicine residency and Medical Oncology fellowship. She completed postdoctoral training at the University of Pennsylvania with Dr. Celeste Simon.
Dr. Rathmell’s work focuses on the treatment and research of complex renal cell carcinomas, and has resulted in more than 200 articles in leading peer-reviewed journals. She is a member of The Cancer Genome Atlas, winning the 2021 American Association for Cancer Research Team Science Award, and serves on numerous boards including the National Cancer Institute’s Board of Scientific Advisors, and the American Physician Scientist Association Board of Directors. She is an elected member of the American Academy of Arts and Sciences and the National Academy of Medicine, and served as ASCI President (2019-20).
This event was moderated by Benjamin D. Humphreys, MD, PhD, 2023-2024 ASCI President, Chief of the Division of Nephrology and the Joseph Friedman Professor at Washington University in St. Louis, and member of the Board of Scientific Counselors for the National Institute of Diabetes and Digestive and Kidney Diseases.
Tippi Cicek MacKenzie, MD
Fetal therapies for single-gene disorders
The American Society for Clinical Investigation is proud to present the ASCI Scientific Sessions: a monthly spotlight on distinguished investigator...